Researchers track osteosarcoma treatments to find what works best
NCT ID NCT04890067
First seen Jun 25, 2026 · Last updated Sep 03, 2026 · Updated 3 times
Summary
This study follows 120 patients with localized osteosarcoma (a bone cancer) to collect information on their treatments and outcomes. It does not test a new drug but observes standard care to learn which approaches lead to better survival and fewer side effects. The goal is to improve future treatment guidelines.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide valuable insights to refine treatment strategies for localized osteosarcoma, potentially improving survival rates.
- What could go wrong
- This is an observational study, not a test of a new treatment. It collects data only, so it cannot directly prove what works best. Results may take years and might not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2021
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A research network
The lead sponsor is a research network or cooperative group.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with localized high grade ostesarcoma of the extremities
- Ages
-
Up to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of high grade OS of the extremities * Age at diagnosis ≤ 40 years at the time of diagnosis * Localized disease (skip metastases are allowed) * Adequate organ function according the AIEOP/ISG OS 2021 recommendation * Patients or parents oe guardians of minors who have given their written informed consent to participate in the study Exclusion Criteria: * Presence of metastases * Diagnosis of periosteal OS, of parosteal OS or secondary OS * Any medical condition which can not allowed the use of the treatments recommended by AIEOP/ISG OS 2021
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Localized osteosarcoma are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
16 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
A.O. Universitaria Meyer
RECRUITINGFlorence, 50139, Italy
-
A.O. Universitaria Policlinico S. Orsola Malpighi di Bologna
RECRUITINGBologna, 40138, Italy
-
ARNAS P. O. "Civico e Benfratelli"
RECRUITINGPalermo, 90127, Italy
-
AUO Policnico G. Rodolico San Marco
RECRUITINGCatania, 95123, Italy
-
Azienda Ospedaliera di Padova UOC Oncoematologia Pediatrica
RECRUITINGPadova, Italy
-
Azienda Ospedaliero Universitaria Consorziale Policlinico - Bari
RECRUITINGBari, 70124, Italy
-
Azienda Ospedaliero-Universitaria Pisana
RECRUITINGPisa, 56126, Italy
-
Centro di Riferimento Oncologico - Unit of Medical Oncology
RECRUITINGAviano, Pordenone, 33081, Italy
-
FONDAZIONE IRCCS Istituto Nazionale dei Tumori
RECRUITINGMilan, Italy
-
Fondazione IRCCS INT Milano SC Pediatria Oncologica
RECRUITINGMilan, Italy
-
IRCCS Istituto ortopedico Rizzoli
RECRUITINGBologna, 40136, Italy
-
IRCCS materno infantile Burlo Garofolo
RECRUITINGTrieste, T, 34137, Italy
-
Istituti Fisioterapici Ospitalieri di Roma
RECRUITINGRoma, Italy
-
Istituto Giannina Gaslini
RECRUITINGGenova, Italy
-
Ospedale Pediatrico Bambin Gesu'
NOT_YET_RECRUITINGRoma, Italy
-
Sandra Aliberti
RECRUITINGCandiolo, Torino, 10060, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.